ArticleBMC cancer2025
Motherhood with HBOC in Israel: experiencing preventive disruption.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study addresses a critical gap in current research by focusing primarily on women who were already mothers when given a diagnosis of Hereditary Breast and Ovarian Cancer Syndrome (HBOC), caused by pathogenic/likely pathogenic (P/LP) variants in BRCA1/2. While extensive literature exists on general experiences of HBOC and pre-parenthood decision-making, the unique challenges faced by mothers remain understudied, particularly within the cultural context of Israel, where family expansion is highly valued.
methodsSemi-structured interviews were conducted with 12 women diagnosed with HBOC (some with previous cancer diagnosis, others without), who became mothers before their diagnosis, and gave birth at least once post-diagnosis. Data was analyzed using thematic analysis to identify patterns and themes within participants’ experiences.
resultsThree themes were generated: (1) transgenerational transfer of cancer – breaking the chain; (2) transgenerational transfer of HBOC to the next generation – a complex decision; and (3) present and future challenges of motherhood with HBOC. Women chose preventive procedures to reduce cancer risk but often declined genetic testing in reproductive planning to avoid passing on the mutation. Disclosure patterns varied widely, as some learned of their HBOC status through multiple affected relatives, while others did so after a single diagnosis. Participants described what we conceptualize as “preventive disruption” – continually negotiating the tension between protective maternal instincts and genetic realities. Whether confronting immediate caregiving challenges or future-oriented anxieties, the emotional burden of genetic risk reshaped motherhood into an experience characterized by vigilance, difficult decision-making, and emotional complexity.
conclusionsGenetic counseling for mothers with HBOC who are considering more children should address PGT-M, medically advised breastfeeding cessation, and communication of genetic risk to children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.